Denali Therapeutics (DNLI) Earnings Date & Reports

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DNLI is expected to report earnings to fall 45.46% to -37 cents per share on November 11

Denali Therapeutics DNLI Stock Earnings Reports

Q3'26

Est.

$-0.37

Q2'26

Missed

by $0.04

Q1'26

Missed

by $0.03

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.01

The last earnings report on August 06 showed earnings per share of -68 cents, missing the estimate of -63 cents. With 242.48K shares outstanding, the current market capitalization sits at 3.35B.

View a ticker or compare two or three

DNLI

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for DNLI